Advanced SearchSearch Tips
Natural Substance MS-10 Improves Women's Health via Regulation of Estrogen Receptor
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Natural Substance MS-10 Improves Women's Health via Regulation of Estrogen Receptor
Noh, Yoo-Hun; Lee, Ji Won; Park, Jiae; Lee, Sang Hyung; Lee, Jun Young; Kim, Sung-Su; Park, Kwang-Kyun; Kim, Tae Jin; Myung, Soon-Chul; Jeong, Yoonhwa;
  PDF(new window)
In this study, the expression level of estrogen receptor in an ovariectomized rat model was effectively enhanced by MS-10, Cirsium japonicum and Thymus vulgaris extract complex, in a reversible manner. MS-10 plays a positive role in enhancing estrogen activity at low concentrations, leading to improved women's health. In order to determine whether or not MS-10 improves menopausal symptoms clinically, a randomized, double-blinded, and placebo-controlled clinical study was carried out on 62 middle-aged women treated with 500 mg of MS-10 or placebo daily for 12 weeks. Clinical menopausal symptoms were evaluated by Kupperman's index (KI) detecting various menopausal symptoms, including hot flushes, parenthesis, insomnia, nervousness, melancholia, dizziness, fatigue, rheumatic pain, palpitations, formication, and headaches. Total KI score decreased significantly by about 18% upon ingestion of MS-10. Colpoxerosis, a main symptom of menopause, was significantly reduced by about 21% upon ingestion of MS-10 in contrast to placebo. In addition, reduction of insulin-like growth factor-1 with age was improved by over 10% upon ingestion of MS-10, whereas there were no significant difference with placebo. No side effects appeared after treatment with MS-10. Thus, MS-10 can be suggested as a plausible natural substance for improving women's health.
MS-10;menopause;colpoxerosis;Kupperman's index;estrogen receptor;
 Cited by
Flavonoids from Cirsium japonicum var. maackii pappus as inhibitors of aldose reductase and their simultaneous determination, Chemical Papers, 2017  crossref(new windwow)
Enns DL, Tiidus PM. 2010. The influence of estrogen on skeletal muscle: sex matters. Sports Med 40: 41-58. crossref(new window)

Nilsson N, Carlsten H. 1994. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation. Cell Immunol 158: 131-139. crossref(new window)

Saint-Criq V, Rapetti-Mauss R, Yusef YR, Harvey BJ. 2012. Estrogen regulation of epithelial ion transport: Implications in health and disease. Steroids 77: 918-923. crossref(new window)

Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, Losordo DW. 2003. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108: 3115-3121. crossref(new window)

Oboti L, Ibarra-Soria X, Perez-Gomez A, Schmid A, Pyrski M, Paschek N, Kircher S, Logan DW, Leinders-Zufall T, Zufall F, Chamero P. 2015. Pregnancy and estrogen enhance neural progenitor-cell proliferation in the vomeronasal sensory epithelium. BMC Biol 13: 104. crossref(new window)

Cummings SR, Rubin SM, Black D. 1990. The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. Clin Orthop Relat Res 1: 163-166.

Holloway D. 2011. An overview of the menopause: assessment and management. Nurs Stand 25: 47-57. crossref(new window)

Nappi RE, Kokot-Kierepa M. 2010. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 67: 233-238. crossref(new window)

Chakrabarti S, Morton JS, Davidge ST. 2014. Mechanisms of estrogen effects on the endothelium: an overview. Can J Cardiol 30: 705-712. crossref(new window)

Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ. 2012. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 97: 1159-1168. crossref(new window)

Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, Cassidy A. 2009. Effects of soy protein and isoflavones on circulating hormone concentrations in preand post-menopausal women: a systematic review and metaanalysis. Hum Reprod Update 15: 423-440. crossref(new window)

Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M. 2003. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349: 523-534. crossref(new window)

Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH. 2001. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med 135: 493-501. crossref(new window)

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613. crossref(new window)

Brinton LA, Richesson D, Leitzmann MF, Gierach GL, Schatzkin A, Mouw T, Hollenbeck AR, Lacey JV Jr. 2008. Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev 17: 3150-3160. crossref(new window)

Noh YH, Kim DH, Lee SA, Yin XF, Park J, Lee MY, Lee WB, Lee SH, Kim JK, Kim SS, Jeong Y, Myung SC, Kim TJ, Kang IJ. 2016. The natural substance MS-10 improves and prevents menopausal symptoms, including colpoxerosis, in clinical research. J Med Food 19: 228-237. crossref(new window)

Choi YJ, Yoon Y, Choi HS, Park S, Oh S, Jeong SM, Suh HR, Lee BH. 2011. Effects of medicinal herb extracts and their components on steatogenic hepatotoxicity in Sk-hep1 cells. Toxicol Res 27: 211-216. crossref(new window)

de la Peña JB, Kim CA, Lee HL, Yoon SY, Kim HJ, Hong EY, Kim GH, Ryu JH, Lee YS, Kim KM, Cheong JH. 2014. Luteolin mediates the antidepressant-like effects of Cirsium japonicum in mice, possibly through modulation of the GABAA receptor. Arch Pharm Res 37: 263-269. crossref(new window)

Liu S, Luo X, Li D, Zhang J, Qiu D, Liu W, She L, Yang Z. 2006. Tumor inhibition and improved immunity in mice treated with flavone from Cirsium japonicum DC. Int Immunopharmacol 6: 1387-1393. crossref(new window)

Yin J, Heo SI, Wang MH. 2008. Antioxidant and antidiabetic activities of extracts from Cirsium japonicum roots. Nutr Res Pract 2: 247-251. crossref(new window)

Büechi S, Vögelin R, von Eiff MM, Ramos M, Melzer J. 2005. Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme. Forsch Komplementarmed Klass Naturheilkd 12: 328-332. crossref(new window)

de la Torre Rodriguez YC, Martínez Estrada FR, Flores Suarez AE, Waksman de Torres N, Salazar Aranda R. 2013. Larvicidal and cytotoxic activities of extracts from 11 native plants from northeastern Mexico. J Med Entomol 50: 310-313. crossref(new window)

Gruenwald J, Graubaum HJ, Busch R. 2006. Evaluation of the non-inferiority of a fixed combination of thyme fluidand primrose root extract in comparison to a fixed combination of thyme fluid extract and primrose root tincture in patients with acute bronchitis. Arzneimittelforschung 56: 574-581.

Shimelis ND, Asticcioli S, Baraldo M, Tirillini B, Lulekal E, Murgia V. 2012. Researching accessible and affordable treatment for common dermatological problems in developing countries. An Ethiopian experience. Int J Dermatol 51: 790-795. crossref(new window)

Walker JM. 1994. The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol 32: 5-8.

Kupperman HS, Blatt MH, Wiesbader H, Filler W. 1953. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 13: 688-703. crossref(new window)

Chae HD, Choi SY, Cho EJ, Cho YM, Lee SR, Lee ES, Park HM. 2014. Awareness and experience of menopausal symptom and hormone therapy in Korean postmenopausal women. J Menopausal Med 20: 7-13. crossref(new window)

Filus A, Zdrojewicz Z. 2015. Insulin-like growth factor-1(IGF-1)-structure and the role in the human body. Pediatr Endocrinol Diabetes Metab 20: 161-169.

Froesch ER, Schmid C, Schwander J, Zapf J. 1985. Actions of insulin-like growth factors. Ann Rev Physiol 47: 443-467. crossref(new window)

Zapf J, Schoenle E, Froesch ER. 1978. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem 87: 285-296. crossref(new window)

Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Muller J, Skakkebaek NE. 1997. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 82: 2497-2502.

Lin CM, Huang YL, Lin ZY. 2009. Influence of gender on serum growth hormone, insulin-like growth factor-I and its binding protein-3 during aging. Yonsei Med J 50: 407-413. crossref(new window)

Kwon JY, Nam TJ. 2005. Effects of phytoestrogen on cell growth and insulin-like growth factor-I (IGF-I) production in MC3T3-E1 cells. J Korean Soc Food Sci Nutr 34: 743-749. crossref(new window)

Alonso A, Gonzalez C. 2012. Neuroprotective role of estrogens: relationship with insulin/IGF-1 signaling. Front Biosci (Elite Ed) 4: 607-619.

Sheng MH, Lau KH, Baylink DJ. 2014. Role of osteocytederived insulin-like growth factor I in developmental growth, modeling, remodeling, and regeneration of the bone. J Bone Metab 21: 41-54. crossref(new window)